drugset / Trial / NCT02537002
Single Dose Study of PF-05230907 in Healthy Japanese Subjects
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study is the following: * To determine the safety and tolerability of single ascending intravenous (IV) doses of PF-05230907 in healthy Japanese subjects. * To characterize the PK profile of single ascending IV doses of PF-05230907 in healthy Japanese subjects. * To characterize the PD profiles of single ascending IV doses of PF-05230907 in healthy Japanese subjects. * To evaluate the immunogenicity of PF-05230907 in healthy Japanese subjects
Timeline
- Start
- 2015-09
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-05230907 | Unknown | 3 ug/kg | Intravenous |
| Subject | PF-05230907 | Unknown | 5 ug/kg | Intravenous |
Indications
No indication recorded.